Contract 36F79718D0456
Melinta Therapeutics, Llc · Department Of Veterans Affairs · May 31, 2018
Melinta Therapeutics, Llc was awarded a federal contract by Department Of Veterans Affairs on May 31, 2018 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 29 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on August 14, 2024. If all options are exercised, the contract could reach $4.20 million.
Contract details
- PIID
- 36F79718D0456
- Award type
- —
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- May 31, 2018
- Latest action
- August 14, 2024
Description
CONTRACT CANCELLATION
Modification timeline
-
August 14, 2024Mod P00030$0
-
June 6, 2024Mod P00029SHORT TERM EXTENSION$0
-
March 22, 2024Mod P00028SHORT TERM EXTENSION$0
-
March 8, 2024Mod P00026PUBLIC LAW LIFECYCLE$0
-
March 8, 2024Mod P00027ADMINISTRATIVE CHANGE$0
-
February 1, 2024Mod P00025TEMPORARY PRICE REDUCTION$0
-
December 21, 2023Mod P00024PUBLIC LAW 2024 PRICING UPDATES$0
-
December 13, 2023Mod P00023ADDITION$0
-
October 26, 2023Mod P00022NDC CHANGE$0
-
September 20, 2023Mod P00021SHORT TERM EXTENSION$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 53,729 | $99.76B |
| 2 | Pfizer Inc | 4,613 | $28.68B |
| 3 | Merck Sharp & Dohme Llc | 391 | $21.58B |
| 4 | Modernatx, Inc. | 3 | $8.20B |
| 5 | Sanofi Vaccines Us Inc. | 5,248 | $7.76B |
| 6 | Glaxosmithkline, Llc | 1,418 | $7.22B |
| 7 | Merck Sharp & Dohme Corp. | 349 | $5.33B |
| 8 | Pfizer Inc. | 3,842 | $4.83B |
| 9 | Eli Lilly And Company | 18 | $4.67B |
| 10 | Amerisourcebergen Drug Corp | 497 | $3.23B |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79718D0456?
Contract 36F79718D0456 is a federal contract awarded to Melinta Therapeutics, Llc by Department Of Veterans Affairs on May 31, 2018 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 29 times since the base award.
Who won contract 36F79718D0456?
Melinta Therapeutics, Llc won contract 36F79718D0456 from Department Of Veterans Affairs.
How much is contract 36F79718D0456 worth?
Contract 36F79718D0456 has obligated $0 to date but carries a potential ceiling of $4.20 million if fully funded and all options are exercised.